Xvivo Perfusion AB (publ) (LON:0RKL)
London · Delayed Price · Currency is GBP · Price in SEK 175.68
+1.16 (0.67%)
At close: Oct 21, 2025
Xvivo Perfusion AB Employees
Xvivo Perfusion AB had 190 employees as of December 31, 2024. The number of employees increased by 30 or 18.75% compared to the previous year.
Employees
190
Change (1Y)
30
Growth (1Y)
18.75%
Revenue / Employee
332.82K GBP
Profits / Employee
12.23K GBP
Market Cap
459.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 190 | 30 | 18.75% |
| Dec 31, 2023 | 160 | 20 | 14.29% |
| Dec 31, 2022 | 140 | 27 | 23.89% |
| Dec 31, 2021 | 113 | 31 | 37.80% |
| Dec 31, 2020 | 82 | 42 | 105.00% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Xvivo Perfusion AB News
- 3 months ago - Xvivo Perfusion AB (XVIPF) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... - GuruFocus
- 3 months ago - Q2 2025 Xvivo Perfusion AB Earnings Call Transcript - GuruFocus